Clinical Operations

Murray Aitken Executive Director, IQVIA Institute for Human Data Science Senior Vice President, IQVIA

Patient Recruitment / Decentralized Hybrid Trials
Patient Recruitment 2.0: Strategies And Approaches For Success In Decentralized Hybrid Trials
-Amit Gulwadi
Vice President, Head of Transformation
Alexion Pharmaceuticals, Inc.

Clinical Technologies & Innovation
The Latest Trends in Electronic Data Capture (EDC) Systems and eClinical Solutions for Digital Transformation in Clinical Operations (Topic TBC)
-Paresh Patel
Global Head, Clinical Intelligence
Otsuka Pharmaceutical Companies (U.S.)

Global Site Selection and Feasibility Study
An In-Depth Exploration of Emerging Trends and Cutting-Edge Best Practices in Elevating Clinical Trial Awareness and Revolutionizing Recruitment Strategies
-James Kirwin
COO and Head, Clinical Development Operations
SFA Therapeutics

Diversity, Equity and Inclusion In Patient Recruitment & Engagement
Implementing Diversity, Equity, and Inclusion (DEI) Initiatives: Insights from Company Case Studies and Exemplary Practices

Clinical Supplies / Storage & Global Networks
A Strategic Discussion on Clinical Supplies, Storage Innovation, and Global Networks Reshaping the Landscape CTM, Storage Facilities, Packaging and Labeling in Clinical Trials
-Jackie Foster
Senior Director, Clinical Supplies
PTC Therapeutics, Inc.

Patient Recruitment / Decentralized Hybrid Trials
Financial Empowerment:
Fueling Site and Patient Engagement for Successful Clinical Trials
Effective financial management is the backbone of successful clinical trials. In this discussion, we’ll explore how strategic financial practices empower trial sites and engage participants, ultimately driving superior trial outcomes for sponsors. By aligning financial processes with trial objectives, we can enhance collaboration, transparency, and overall trial efficiency.
–Aligning financial stakeholders—sponsors, CROs, sites, and patients
–Understanding the financial impact on patients and sites
–Integrating financial decisions with trial objectives
-James DiCesare
Vice President, Financial Management Solutions
IQVIA Technologies

IQVIA Technologies

Clinical Technologies & Innovation
The Future Of Clinical Trials Embracing Early Signal Prediction And Simulations For Enhanced Outcomes
This theme captures the essence of our vision for a more efficient, secure, and ethically grounded approach to clinical trials.
– Integration of multiple data sources – the importance of leveraging diverse data sets to build predictive models that enhance safety, assess trial feasibility, and simulate trial arms with precision
–Security and privacy in data utilization – strategies to maintain high standards of data security and privacy while fostering the development of robust predictive models
– Human-machine synergy – the critical role of integrating medical reviews and human insights to refine predictive models, enhancing their reliability and ethical standards
–Future trajectory and practical use cases – exploration of real-world applications and the prospective impact of signal prediction and SIM models on clinical trial planning, monitoring, and execution
-Naouel Baili
Director, AI Scientist
IQVIA Technologies

Sponsor

Global Site Selection and Feasibility Study
Making Progress in Study Start-Up in The Face of Industry Headwinds
– What sub-processes have you identified to be slowing down study start-ups?
–Is the situation with site capacity improving yet, or are budgets continuing to increase?
– What process and technology solutions for site activation have been successful and what hasn’t been as effective as hoped?
-KK Rumrill
Senior Director, Site Suite
IQVIA Technologies

IQVIA Technologies

Diversity, Equity and Inclusion In Patient Recruitment & Engagement
Navigating The Future Involves Pioneering Strategies For Diversity, Equity And Inclusion In Patient Recruitment And Engagement Through Comprehensive Demographic Data Collection

SPONSOR

Clinical Supplies / Storage & Global Networks
Supply Chain Initiatives that Improve Accountability, Optimization, and Sustainability in IP Management
Discussion Points:
– Improving supply chain optimization and cost efficiencies through intelligent integrations & automation
– Ensuring quality control and assurance in cold chain management
– Tools and strategies to improve drug accountability and facilitate the move to remote monitoring.
– Optimizing trial processes for sites and patients with the right data and integration strategies
-Kevin Landells
VP, Business Head for IRT
IQVIA Technologies

IQVIA Technologies

Patient Recruitment / Decentralized Hybrid Trials
How Are Emerging Biopharma Firms Tackling Infrastructure Challenges To Expedite Drug Development?
-Karrie Hilsinger
Senior Director, Head of Clinical Operations
UroGen Pharma

Clinical Technologies & Innovation
AI and ML In 2024:
Innovations Reshaping Clinical Trial Supply Chains
-Barry Moore
Head, Randomization and Trial Supply Management
GSK

Global Site Selection and Feasibility Study
Embarking on the Pinnacle of Clinical Trial Success in 2024: Unveiling Global Site Selection Strategies, Where Patient Population Precision Aligns with Study Criteria, and Ethical and Cultural Considerations Illuminate the Path to Ethical and Culturally Sensitive Trials

Diversity, Equity and Inclusion In Patient Recruitment & Engagement
Involving Patients In Decision Making Exploring A Scope Of Strategies Statements And Transformations For Engaging Underrepresented Communities And Patient Engagement
-Eve Dryer
Vice President, Patient Advocacy
Travere Therapeutics

Clinical Supplies / Storage & Global Networks
Mastery Of Clinical Logistics:
Unleashing The Power Of Quality Control And Assurance In Clinical Supplies Storage

Your Pre-Selected Private Meetings

Patient Recruitment / Decentralized Hybrid Trials
Managing The Complications Of Collaborations: Obstacles And Resolutions In Outsourcing For Developing Biotech Pharma Companies (Topic TBC)
-Teresa DeVincentis
Head, Clinical Quality & Risk Management,
ADC Therapeutics

Clinical Technologies & Innovation
Harnessing The Power Of Digital Platforms For Enhanced Monitoring (EMC), Communication, And Decision Making Across The Clinical Trial Ecosystem In Global Clinical Trials
-Amit Gulwadi
Vice President, Head of Transformation
Alexion Pharmaceuticals, Inc.

Global Site Selection and Feasibility Study
How Can Sponsors and Researchers Harness the Power of Global Site Selection and Feasibility Studies to Anticipate Challenges and Optimize Conditions for Successful Global-Scale Trials?
-Uday Harle
Assitant Vice President and Head, Global Clinical Research
Kashiv Biosciences

Diversity, Equity and Inclusion In Patient Recruitment & Engagement
Eliminating Health Inequities: How Can We Improve The Diverse Representation Of Clinical Trial Programs To Drive Health Equity?

Clinical Supplies / Storage & Global Networks
Strategies And Approaches For Seamless Integration Of Clinical Supplies Storage Global Networks And Regulatory Compliance Through Dynamic Partnerships And Supplier Networks
-Brian Dole
Vice President, Global Clinical Supply Chain
Bristol Myers Squibb